Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to find out what the maximum tolerated dose is for an
experimental drug called AZD7762 when given with the approved drug gemcitabine based on the
side effects experienced by patients that receive both drugs.